BERLIN, Oct. 25, 2023 (GLOBE NEWSWIRE) — Curium, a world chief in nuclear medication, and PIUR IMAGING, a European medical machine firm on the forefront of pioneering tomographic 3D ultrasound options, introduced at this time a strategic partnership to advance thyroid diagnostics in Germany.
Under the phrases of the partnership settlement, PIUR IMAGING will present and constantly develop the {hardware} and software program resolution, with Curium answerable for the unique distribution of the product in nuclear medication in Germany.
Ciril Faia, CEO SPECT Europe at Curium, commented: “The partnership announced today with PIUR IMAGING in Germany represents an exciting leap forward in medical imaging, with the potential to impact cancer patient care and treatment outcomes. As we focus on redefining the experience of cancer through our trusted legacy in nuclear medicine, this partnership builds on Curium’s expertise, capacity, and global track record in the development and delivery of diagnostic and therapeutic solutions by leveraging PIUR’s ‘tUS Infinity’ AI-driven imaging.”
The PIUR tUS Infinity, provided by PIUR IMAGING, seamlessly turns normal ultrasound methods into tomographic 3D imaging gadgets. This resolution supplies healthcare professionals with full quantity acquisitions and 3D evaluation of the thyroid organ and potential nodules. Powered by AI-driven software program for proposal of nodule classification based mostly on ACR-TIRADS standards and outfitted with complete documentation capabilities of diagnostic outcomes, the PIUR tUS Infinity not solely streamlines workflow effectivity but in addition enhances transparency and reproducibility, taking thyroid diagnostics to the following degree.
Robert Bauer, Chief Technology Officer at PIUR IMAGING, commented, “Our collaboration with Curium is a major milestone for PIUR and our progress in Germany. Leveraging Curium’s in depth community and our progressive tomographic 3D resolution, we’re poised to redefine thyroid imaging in Germany and past.”
For extra details about PIUR IMAGING and its tomographic 3D ultrasound imaging options, please go to https://piurimaging.com/.
About Curium
Curium is a world chief in nuclear medication. We develop, manufacture, and distribute world-class radiopharmaceutical merchandise to assist sufferers across the globe. Our confirmed heritage mixed with a pioneering strategy are the hallmarks to ship innovation, excellence, and unparalleled service.
With manufacturing services throughout Europe and the United States, Curium delivers SPECT, PET and therapeutic radiopharmaceutical options for life-threatening ailments to over 14 million sufferers yearly. The identify ‘Curium’ honors the legacy of pioneering radioactive supplies researchers Marie and Pierre Curie, after whom the radioactive factor curium was named and emphasizes our deal with nuclear medication. To be taught extra, go to www.curiumpharma.com
For extra info:
Ross Bethell
VP, Head of Global Communications
[email protected]
About PIUR IMAGING
PIUR IMAGING is a Europe-based medical machine firm targeted on enhancing healthcare diagnostics. Leveraging the ability of AI, we focus on tomographic 3D ultrasound imaging options, seamlessly built-in with present ultrasound gadgets. Our superior 3D imaging expertise permits complete quantity measurements of total organs and constructions, considerably bettering documentation, transparency, and objectivity in ultrasound examinations. With exact AI-assisted evaluation and reporting, our software program ensures larger reproducibility and workflow effectivity. From the prognosis to the monitoring of thyroid nodules and numerous anomalies, we empower medical professionals to enhance their diagnostic workflow in addition to pre- and post-treatment care. For additional info, go to: https://piurimaging.com/
For extra info:
PIUR IMAGING
Stacey Hong
Marketing Manager
[email protected]
+43 – 676 – 373 59 36
